RESUMEN
BACKGROUND: The composition of the graft used for allogeneic hematopoietic stem cell transplantation (HSCT) is important for the treatment outcome. Different apheresis devices may yield significant differences in peripheral blood stem cell graft cellular composition. We compared stem cell grafts produced by Cobe Spectra (Cobe) and Spectra Optia (Optia) with use of the mononuclear cell (MNC) protocol, and evaluated clinical outcome parameters such as graft-versus-host disease (GvHD), transplant-related mortality (TRM), relapse, and overall survival. STUDY DESIGN AND METHODS: During 5 years, 31 Cobe Spectra and 40 Spectra Optia grafts were analyzed for CD34, CD3, CD4, CD8, CD19, and CD56 cell content. Clinical outcome parameters were correlated and compared between the two patient groups using different apheresis devices. RESULTS: Optia grafts contained fewer lymphocytes compared to Cobe (p < 0.001). Optia grafts had a significantly lower incidence of acute GvHD Grades II through IV (Cobe 45% vs. Optia 23%; p = 0.039) and TRM (16% vs. 2.5%; p < 0.05) but higher chronic GvHD (32% vs. 67%; p = 0.005) compared to Cobe grafts. Finally, the multivariate analysis showed a significant correlation among the different apheresis devices and both acute GvHD II through IV and severe chronic GvHD. The multivariate analysis also showed a significant correlation between the CD3+ cell dose and the incidence of severe acute GvHD. CONCLUSION: Optia-obtained grafts yielded a lower acute GvHD Grades II-IV and TRM risk, but had no impact on relapse or overall survival in this study. Understanding and further improvement of peripheral blood stem cell (PBSC) apheresis techniques may be used in the future to personalize HSCT by, for example, fine-tuning the GvHD incidence.
Asunto(s)
Eliminación de Componentes Sanguíneos/instrumentación , Enfermedad Injerto contra Huésped/etiología , Donantes de Tejidos , Trasplante Homólogo/efectos adversos , Enfermedad Aguda , Adulto , Antígenos CD/sangre , Eliminación de Componentes Sanguíneos/normas , Complejo CD3/sangre , Femenino , Enfermedad Injerto contra Huésped/mortalidad , Humanos , Incidencia , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Trasplante de Células Madre de Sangre Periférica/efectos adversos , Trasplante de Células Madre de Sangre Periférica/métodos , Trasplante de Células Madre de Sangre Periférica/mortalidad , Recurrencia , Análisis de Supervivencia , Trasplante Homólogo/mortalidadRESUMEN
AIM: The aim of this study was to coordinate the structured psychosocial, neurocognitive and educational follow-up of children treated for brain tumours with the medical protocol and apply the model in two Swedish healthcare regions. METHODS: We invited all children living in the two regions, who had been diagnosed with a brain tumour from October 1, 2010, through June 30, 2012, to participate along with their parents. The follow-up programme evaluated the emotional status of the parents and patients and assessed the children's general cognitive level, working memory, speed of performance, executive functions and academic achievement from diagnosis through to adult care. RESULTS: During the study period, 61 children up to the age of 17.1 years were diagnosed with a brain tumour, but 18 of these were excluded for various reasons. The majority of the mothers (70%) displayed significantly poor emotional status, as did 34% of the fathers and 21% of the children. The majority of the children (57%) also showed poor neurocognitive performance and needed special adaptations at school (66%). CONCLUSION: Our findings indicate the need for coordinated, multiprofessional follow-up programmes, well anchored in the healthcare organisation, for children diagnosed with brain tumours.
Asunto(s)
Neoplasias Encefálicas/rehabilitación , Adolescente , Neoplasias Encefálicas/psicología , Niño , Preescolar , Cognición , Evaluación Educacional , Femenino , Humanos , Lactante , Masculino , Padres/psicología , Estudios ProspectivosRESUMEN
Parkinson's disease (PD) is characterised by the progressive loss of nigral dopamine neurons and the presence of synucleinopathy. Overexpression of α-synuclein in vivo using viral vectors has opened interesting possibilities to model PD-like pathology in rodents. However, the attempts made so far have failed to show a consistent behavioural phenotype and pronounced dopamine neurodegeneration. Using a more efficient adeno-associated viral (AAV) vector construct, which includes a WPRE enhancer element and uses the neuron-specific synapsin-1 promoter to drive the expression of human wild-type α-synuclein, we have now been able to achieve increased levels of α-synuclein in the transduced midbrain dopamine neurons sufficient to induce profound deficits in motor function, accompanied by reduced expression of proteins involved in dopamine neurotransmission and a time-dependent loss of nigral dopamine neurons, that develop progressively over 2-4 months after vector injection. As in human PD, nigral cell loss was preceded by degenerative changes in striatal axons and terminals, and the appearance of α-synuclein positive inclusions in dystrophic axons and dendrites, supporting the idea that α-synuclein-induced pathology hits the axons and terminals first and later progresses to involve also the cell bodies. The time-course of changes seen in the AAV-α-synuclein treated animals defines distinct stages of disease progression that matches the pre-symptomatic, early symptomatic, and advanced stages seen in PD patients. This model provides new interesting possibilities for studies of stage-specific pathologic mechanisms and identification of targets for disease-modifying therapeutic interventions linked to early or late stages of the disease.
Asunto(s)
Síntomas Conductuales/genética , Neuronas Dopaminérgicas/metabolismo , Vectores Genéticos/fisiología , Mesencéfalo/patología , Enfermedades Neurodegenerativas/genética , alfa-Sinucleína/genética , Anfetamina/farmacología , Análisis de Varianza , Animales , Antiparkinsonianos/farmacología , Antiparkinsonianos/uso terapéutico , Síntomas Conductuales/etiología , Recuento de Células , Cromatografía Líquida de Alta Presión , Dependovirus/genética , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Dopamina/metabolismo , Neuronas Dopaminérgicas/patología , Proteínas ELAV/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Regulación de la Expresión Génica/genética , Proteínas Fluorescentes Verdes/genética , Humanos , Levodopa/farmacología , Levodopa/uso terapéutico , Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/etiología , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/genética , Ratas , Ratas Sprague-Dawley , Elementos Reguladores de la Transcripción/genética , Conducta Estereotipada/efectos de los fármacos , Conducta Estereotipada/fisiología , Factores de Tiempo , Tirosina 3-Monooxigenasa/metabolismo , Proteínas de Transporte Vesicular de Monoaminas/metabolismo , alfa-Sinucleína/metabolismoRESUMEN
Life cycle assessment (LCA) has been used in waste management for the last two decades and hundreds of journal papers have been published. The use of LCA in waste management has provided a much-improved holistic view of waste management including waste flows and potential environmental impacts. Although much knowledge has been obtained from LCA studies, there is still a need to use LCA models in integrated waste management. This paper describes six areas where LCA is expected to play a role in waste management in the future: 1) understanding an existing waste management system; 2) improving existing waste management systems; 3) comparing alternative technologies/ technology performance; 4) technology development/prospective technologies; 5) policy development/strategic development; and 6) reporting. Illustrative examples are provided for each application area.
Asunto(s)
Eliminación de Residuos , Administración de Residuos , Ambiente , Formulación de Políticas , Estudios ProspectivosRESUMEN
It is firmly established that poor metabolic control in diabetes inhibits beta cell function. Chronic hyperglycaemia is probably the most important factor, exerting both primary negative effects (by glucose per se and/or metabolites) and secondary ones (by beta cell exhaustion). Dyslipidemia in diabetes aggravates the glucose effects both by inducing insulin resistance and by direct effects on beta cells. Much experimental and some clinical evidence indicates that therapies that promote "beta cell rest" such as early and intensive insulin treatment and K-ATP channel blockers can be beneficial.
Asunto(s)
Diabetes Mellitus/fisiopatología , Células Secretoras de Insulina/metabolismo , Células Secretoras de Insulina/patología , Adaptación Fisiológica/efectos de los fármacos , Animales , Supervivencia Celular/efectos de los fármacos , Diabetes Mellitus/terapia , Glucosa/toxicidad , Humanos , Células Secretoras de Insulina/efectos de los fármacos , Lípidos/toxicidadRESUMEN
The growth of new axonal sprouts was studied from transected, ascending noradrenergic axons into transplants of iris tissue in the caudal hypothalamus of the rat. A single intraventricular injection of nerve growth factor, given at the time of axonal damage, resulted in an increased formation and growth of new noradrenaline sprouts 7 days later. The effect seemed to be proportional to the administered dose of nerve growth factor.
Asunto(s)
Axones/fisiología , Sistema Nervioso Central/fisiología , Factores de Crecimiento Nervioso/farmacología , Regeneración Nerviosa/efectos de los fármacos , Animales , Axones/análisis , Ventrículos Cerebrales , Femenino , Colorantes Fluorescentes , Histocitoquímica , Hipotálamo/cirugía , Inyecciones , Iris/inervación , Iris/trasplante , Mesencéfalo/cirugía , Factores de Crecimiento Nervioso/administración & dosificación , Norepinefrina/análisis , RatasRESUMEN
Implants of embryonic neural tissue from all regions of the neuraxis survive grafting to the brains of adult rats. After implantation, neurogenesis and differentiation continue, and connections are formed with the mature host brain. Thus, the intracephalic implants provide excellent model systems for studying cellular interactions that regulate synaptogenesis and determine the cytoarchitectonic organization of developing neural tissues.
Asunto(s)
Encéfalo/embriología , Médula Espinal/embriología , Animales , Diferenciación Celular , Sistema Nervioso Central/citología , Sistema Nervioso Central/trasplante , Femenino , Hipocampo/embriología , Locus Coeruleus/embriología , Métodos , Vaina de Mielina/ultraestructura , Regeneración Nerviosa , Vías Nerviosas/embriología , Neuroglía/fisiología , RatasRESUMEN
Dissociated cell suspensions, prepared from the substantia nigra and septal regions of rat embryos, can be grafted to the depths of the caudate-putamen and hippocampus of aged rats. The grafts were rich in dopamine-containing and acetylcholinesterase-positive neurons and had produced extensive new dopaminergic and cholinergic terminal networks in the host neostriatum and hippocampus, respectively. The intrastriatal dopaminergic grafts were associated with a significant improvement in motor coordination in the aged rats. This result suggests that the intracerebral grafting technique may provide a new tool for exploring the role of dopaminergic and cholinergic deficits in the neurological and behavioral impairments associated with aging.
Asunto(s)
Envejecimiento , Cuerpo Estriado/fisiología , Sustancia Negra/trasplante , Acetilcolina/fisiología , Animales , Dopamina/fisiología , Femenino , Hipocampo/fisiología , Actividad Motora/fisiología , Trastornos del Movimiento/fisiopatología , Ratas , Tabique Pelúcido/fisiología , Sustancia Negra/fisiologíaRESUMEN
Transplants of embryonic substantia nigra reinnervated the striatum and were able to sustain intracranial self-stimulation in rats with brain lesions induced by 6-hydroxydopamine. Dopaminergic drugs and alterations in current intensity produced typical changes in response rates. Animals with electrodes implanted into cortical grafts or into the denervated striatum failed to exhibit self-stimulation. These findings suggest that transplanted dopamine neurons convey specific, temporally organized information axonally to the striatum.
Asunto(s)
Cuerpo Estriado/citología , Dopamina/fisiología , Autoestimulación/fisiología , Sustancia Negra/trasplante , Animales , Núcleo Caudado/citología , Dextroanfetamina/farmacología , Femenino , Flupentixol/farmacología , Putamen/citología , RatasRESUMEN
Grafts of fetal septal tissue rich in cholinergic neurons were implanted as a dissociated cell suspension into the depth of the hippocampal formation in aged rats with severe impairments in spatial learning abilities. After 2 1/2 to 3 months, the rats with grafts, but not the controls, had improved their performance in a spatial learning test. Their improvement was due, at least in part, to an increased ability to use spatial cues in the task. In all animals the grafts had produced an extensive acetylcholinesterase-positive terminal network in the surrounding host hippocampal formation. Thus, the action of cholinergic neurons in the graft onto elements in the host hippocampal circuitry may be a necessary, but perhaps not sufficient, prerequisite for the observed functional recovery.
Asunto(s)
Hipocampo/trasplante , Aprendizaje , Trastornos de la Memoria/fisiopatología , Envejecimiento , Animales , Modelos Animales de Enfermedad , Femenino , Feto , Hipocampo/embriología , Hipocampo/crecimiento & desarrollo , Humanos , Ratas , Ratas EndogámicasRESUMEN
Stresses associated with the diabetic state participate in the demise of beta-cells and therapies that eliminate or reduce such stresses are much needed. K-ATP channel openers, of which diazoxide is the most studied, are potentially useful because experimental studies show that they can counteract chronic over-stimulation of beta-cells and protect against toxic conditions, including relative hypoxia. Several mechanisms may underlie the beneficial effects of diazoxide; these may include both indirect (counteracting over-stimulation) and direct mitochondrial effects. Side effects of diazoxide have limited its use in human trials. We have tested lower doses than previously of diazoxide and thereby largely eliminated side effects. In this setting, we demonstrate positive effects on beta-cell function in type 2 diabetic patients who were simultaneously treated with bedtime insulin. However, such effects were absent in insulin-naïve patients. In newly diagnosed type 1 diabetic patients, a 6-month intervention with diazoxide failed to result in better preservation of beta-cell function. K-ATP channel openers have a potential to improve beta-cell function in subgroups of type 2 diabetes patients. Analogues of diazoxide with more potency in relation to side effects would heighten the possibilities for K-ATP channel openers to be of therapeutic use in type 1 diabetes.
Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diazóxido/farmacología , Hipoglucemiantes/farmacología , Insulina/farmacología , Islotes Pancreáticos/efectos de los fármacos , Canales KATP/efectos de los fármacos , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Diazóxido/administración & dosificación , Humanos , Hipoglucemiantes/administración & dosificación , Islotes Pancreáticos/metabolismo , Canales KATP/metabolismoRESUMEN
Modified lipoproteins can negatively affect beta cell function and survival. However, the mechanisms behind interactions of modified lipoproteins with beta cells - and in particular, relationships to increased uptake - are only partly clarified. By over-expressing the scavenger receptor CD36 (Tet-on), we increased the uptake of fluorescent low-density modified lipoprotein (oxLDL) into insulin-secreting INS-1 cells. The magnitude of uptake followed the degree of CD36 over-expression. CD36 over-expression increased concomitant efflux of 3H-cholesterol in proportion to the cellular contents of 3H-cholesterol. Exposure to concentrations of oxLDL from 20 to 100 µg/mL dose-dependently increased toxicity (evaluated by MTT) as well as apoptosis. However, the increased uptake of oxLDL due to CD36 over-expression did not exert additive effects on oxLDL toxicity - neither on viability, nor on glucose-induced insulin release and cellular content. Reciprocally, blocking CD36 receptors by Sulfo-N-Succinimidyl Oleate decreased the uptake of oxLDL but did not diminish the toxicity. Pancreatic islets of CD36-/- mice displayed reduced uptake of 3H-cholesterol-labeled oxLDL vs wild type but similar toxicity to oxLDL. OxLDL was found to increase the expression of CD36 in islets and INS-1 cells. In summary, given the experimental conditions, our results indicate that (1) increased uptake of oxLDL is not responsible for toxicity of oxLDL, (2) increased efflux of the cholesterol moiety of oxLDL counterbalances, at least in part, increased uptake and (3) oxLDL participates in the regulation of CD36 in pancreatic islets and in INS-1 cells.
Asunto(s)
Células Secretoras de Insulina/metabolismo , Lipoproteínas LDL/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Transporte Biológico/fisiología , Antígenos CD36/genética , Antígenos CD36/metabolismo , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Colesterol/metabolismo , Doxiciclina/farmacología , Citometría de Flujo , Insulina/metabolismo , Células Secretoras de Insulina/efectos de los fármacos , Lipoproteínas LDL/farmacología , Masculino , Ratones , Microscopía Confocal , Ratas , Reacción en Cadena en Tiempo Real de la PolimerasaRESUMEN
The developmental potential of neural progenitors derived from the E13.5-E14 lateral or medial ganglionic eminences (LGE and MGE, respectively) or the E12 ventral mesencephalon (VM) was examined in cross-species transplantation model. After injection into the E15 rat forebrain ventricle, mouse LGE progenitors (unlike those of the MGE or VM) were consistently integrated into the host striatum, expressing neurochemical phenotypes and axonal projections characteristic of striatal projection neurons. Additionally, both LGE and MGE precursors displayed widespread incorporation into distinct forebrain and midbrain structures, whereas the more caudally derived VM cells were largely confined to midbrain structures. These results suggest that many LGE precursors are positionally specified for striatal incorporation, while a portion also possess greater potential reflected in more widespread integration following intraventricular injection.
Asunto(s)
Ventrículos Cerebrales/embriología , Cuerpo Estriado/embriología , Embrión de Mamíferos/fisiología , Prosencéfalo/embriología , Trasplante de Células Madre , Células Madre/citología , Animales , Biomarcadores , Diferenciación Celular , Cuerpo Estriado/citología , Ratones , Ratones Endogámicos , Neuronas/fisiología , Fenotipo , Ratas , Ratas Sprague-Dawley , Células Madre/fisiología , Transmisión Sináptica , Trasplante HeterólogoRESUMEN
A highly NGF-secreting cell line was generated by retroviral transduction of a conditionally immortalized CNS-derived neural progenitor cell line. After transplantation to the nucleus basalis magnocellularis (NBM), the cells continue to express the NGF transgene for at least 10 weeks, producing sufficient NGF to reverse cholinergic neuron atrophy in aged rats and induce cellular hypertrophy in young rats. In cognitively impaired aged rats, transplants of the NGF-secreting cells placed either in the NBM and septum or in only the NBM induced a near-complete reversal of the spatial learning impairment. This was accompanied by a normalization of the size of the cholinergic neurons in the grafted areas. The results demonstrate that locally increased supply of NGF to the basal forebrain cholinergic nuclei has a significant impact on cognitive function and support the usefulness of neural progenitor cells for a long-term localized delivery of neurotrophins to the CNS.
Asunto(s)
Envejecimiento/psicología , Trasplante de Tejido Encefálico , Línea Celular Transformada/trasplante , Trastornos del Conocimiento/terapia , Terapia Genética , Factores de Crecimiento Nervioso/uso terapéutico , Sustancia Innominada , Factores de Edad , Envejecimiento/patología , Animales , Tamaño de la Célula , Supervivencia Celular , Trastornos del Conocimiento/patología , Femenino , Expresión Génica , Genes Sintéticos , Supervivencia de Injerto , Hipocampo/citología , Discapacidades para el Aprendizaje/terapia , Aprendizaje por Laberinto/fisiología , Trastornos de la Memoria/terapia , Factores de Crecimiento Nervioso/genética , Factores de Crecimiento Nervioso/metabolismo , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes de Fusión/metabolismo , Tabique Pelúcido/patología , Sustancia Innominada/patología , Factores de TiempoRESUMEN
Fibroblastic 3T3 and endocrine RIN cells were genetically modified by infection with a recombinant retrovirus encoding the form I of human tyrosine hydroxylase (TH) and selection in tyrosine-free medium. These cells were grafted to rats unilaterally lesioned with 6-hydroxy-dopamine. Both cell types survived implantation into the striatum, expressed TH immunoreactivity, and as assessed by microdialysis 8-9 days after implantation, secreted high amounts of DOPA and/or dopamine into the surrounding host striatum. The modified 3T3 cells secreted large amounts of DOPA that was efficiently decarboxylated to dopamine by the host striatal tissue; the newly synthesized dopamine was stored only to a limited extent in the denervated striatum. The modified RIN cells synthesized dopamine that was stored intracellularly and released in a regulated fashion. The grafted DOPA-secreting cells produced 4-5 times higher extracellular dopamine levels than the dopamine-secreting cells, and they were more efficient in reducing apomorphine-induced rotation. No effect was observed with either cell type on amphetamine-induced turning behavior.
Asunto(s)
Cuerpo Estriado/fisiología , Dihidroxifenilalanina/metabolismo , Dopamina/metabolismo , Glándulas Endocrinas/metabolismo , Fibroblastos/metabolismo , Ingeniería Genética , Animales , Conducta Animal , Catecoles/metabolismo , Desnervación , Diálisis/métodos , Glándulas Endocrinas/citología , Fibroblastos/trasplante , HumanosRESUMEN
Adult cholinergic interneurons of the neostriatum are not immunoreactive for monoclonal antibody to NGF receptor, whereas the developing neostriatum is immunoreactive for this same antibody. Chronic NGF infusion into the adult neostriatum resulted in reexpression of the NGF receptor such that many cholinergic interneurons became immunoreactive for NGF receptor. NGF infusion dramatically increased the size and choline acetyltransferase immunoreactivity of these same cholinergic neurons. Additionally, in situ hybridization demonstrated an increase in the number of cells expressing NGF receptor mRNA in the NGF-infused striatum. These findings indicate that central cholinergic neurons which lose their NGF receptors during postnatal development will resume their NGF responsiveness when the tissue is damaged. Such a damage-induced mechanism may act to enhance the action of trophic factors, including NGF, released at the site of injury and enhance the responsiveness of damaged CNS neurons to exogenously administered trophic factors.
Asunto(s)
Colina O-Acetiltransferasa/metabolismo , Cuerpo Estriado/metabolismo , Expresión Génica/efectos de los fármacos , Factores de Crecimiento Nervioso/farmacología , Neuronas/metabolismo , Receptores de Superficie Celular/genética , Envejecimiento , Animales , Anticuerpos Monoclonales , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/crecimiento & desarrollo , Femenino , Proteína Ácida Fibrilar de la Glía/análisis , Factores de Crecimiento Nervioso/metabolismo , Neuronas/efectos de los fármacos , ARN Mensajero/genética , Ratas , Ratas Endogámicas , Receptores de Factor de Crecimiento Nervioso , Valores de Referencia , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
In animal models, immature neural precursors can replace lost neurons, restore function and promote brain self-repair. Clinical trials in Parkinson's disease suggest that similar approaches may also work in the diseased human brain. But how realistic is it that cell replacement can be developed into effective clinical therapy?
Asunto(s)
Encéfalo/citología , Trasplante de Células/tendencias , Enfermedades del Sistema Nervioso Central/terapia , Neuronas/trasplante , Trasplante de Células Madre , Animales , Encéfalo/embriología , Trasplante de Células/métodos , Ensayos Clínicos como Asunto , Epilepsia/terapia , Humanos , Enfermedad de Huntington/terapia , Enfermedad de Parkinson/terapia , Ratas , Recuperación de la Función , Convulsiones/prevención & control , Accidente Cerebrovascular/terapia , PorcinosRESUMEN
Synaptic dopamine release from embryonic nigral transplants has been monitored in the striatum of a patient with Parkinson's disease using [11C]-raclopride positron emission tomography to measure dopamine D2 receptor occupancy by the endogenous transmitter. In this patient, who had received a transplant in the right putamen 10 years earlier, grafts had restored both basal and drug-induced dopamine release to normal levels. This was associated with sustained, marked clinical benefit and normalized levels of dopamine storage in the grafted putamen. Despite an ongoing disease process, grafted neurons can thus continue for a decade to store and release dopamine and give rise to substantial symptomatic relief.
Asunto(s)
Trasplante de Tejido Encefálico , Dopamina/metabolismo , Trasplante de Tejido Fetal , Neuronas/trasplante , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/cirugía , Anciano , Sitios de Unión/efectos de los fármacos , Núcleo Caudado/efectos de los fármacos , Núcleo Caudado/metabolismo , Supervivencia de Injerto , Humanos , Masculino , Metanfetamina/administración & dosificación , Metanfetamina/metabolismo , Metanfetamina/farmacología , Persona de Mediana Edad , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/fisiopatología , Putamen/efectos de los fármacos , Putamen/metabolismo , Racloprida/metabolismo , Receptores de Dopamina D2/metabolismo , Sustancia Negra/citología , Sustancia Negra/embriología , Sustancia Negra/trasplante , Sinapsis/efectos de los fármacos , Sinapsis/metabolismo , Factores de Tiempo , Tomografía Computarizada de Emisión , Resultado del TratamientoRESUMEN
Infectious complications remain a major problem contributing to significant mortality after hematopoietic allogeneic stem cell transplantation (HSCT). Few studies have previously analyzed mortality due to late infections. Forty-four patients dying from an infectious complication were identified from a cohort of 688 consecutive patients surviving more than 6 months without relapse. A control group of 162 patients was selected using the year of HSCT as the matching criterion. Out of 44 patients, 30 (68%) died from pneumonia, 7/44 (16%) from sepsis, 5/44 (11%) from central nervous system infection and 2/44 (4.5%) from disseminated varicella. The cumulative incidences of different types of infection were 1.6% for viral, 1.5% for bacterial and 1.3% for fungal infections and 0.15% for Pneumocystis jirovecii pneumonia. The majority (66%) of the lethal infections occurred within 18 months after HSCT. Acute GVHD (relative risk (RR): 7.19, P<0.0001), chronic GVHD (RR: 6.49, P<0.001), CMV infection (RR: 4.69, P=0.001), mismatched or unrelated donor (RR: 3.86, P=0.004) and TBI (RR: 2.65, P=0.047) were independent risk factors of dying from a late infection. In conclusion, infections occurring later than 6 months after HSCT are important contributors to late non-relapse mortality after HSCT. CMV infection or acute GVHD markedly increase the risk.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas/mortalidad , Infecciones/mortalidad , Adolescente , Adulto , Estudios de Casos y Controles , Infecciones del Sistema Nervioso Central/mortalidad , Niño , Preescolar , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Lactante , Infecciones/etiología , Persona de Mediana Edad , Neumonía/mortalidad , Estudios Retrospectivos , Factores de Riesgo , Sepsis/mortalidad , Suecia/epidemiología , Trasplante Homólogo/mortalidadRESUMEN
Immortalized multipotent neural stem and progenitor cells have emerged as a highly convenient source of tissue for genetic manipulation and ex vivo gene transfer to the CNS. Recent studies show that these cells, which can be maintained and genetically transduced as cell lines in culture, can survive, integrate and differentiate into both neurons and glia after transplantation to the intact or damaged brain. Progenitors engineered to secrete trophic factors, or to produce neurotransmitter-related or metabolic enzymes can be made to repopulate diseased or injured brain areas, thus providing a new potential therapeutic tool for the blockade of neurodegenerative processes and reversal of behavioural deficits in animal models of neurodegenerative diseases. With further technical improvements, the use of immortalized neural progenitors may bring us closer to the challenging goal of targeted and effective CNS repair.